Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 22 November 2017

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Anal human papillomavirus infection in HIV-infected persons

Anal human papillomavirus infection and anal squamous intraepithelial lesions may be acquired in the absence of anal intercourse in HIV-positive men, find researchers in the latest issue of the Annals of Internal Medicine.

News image

fiogf49gjkf04

Anal cancer and its precursor lesion, anal squamous intraepithelial lesions (SILs), are associated with human papillomavirus (HPV) infection.

Anal HPV infection and anal SIL are common in HIV-positive men who have sex with men. Receptive anal intercourse has been presumed to be the mode of acquisition of HPV.

46% of the 50 heterosexual men studied had anal HPV infection.
Annals of Internal Medicine

In this study, researchers from France and the United States assessed the prevalence and risk factors for anal HPV infection and anal SIL in HIV-positive men with no history of anal intercourse.

The research team studied 50 HIV-positive male injection drug users with no history of anal intercourse. They also assessed 67 HIV-infected men who had sex with men. Study subjects were evaluated using cytologic, histologic, and anal HPV DNA testing.

The researchers found that 46% of the 50 heterosexual men had anal HPV infection. In addition, low-grade SIL (LSIL) was found in 16% of these patients and high-grade SIL (HSIL) in 18%.

The team also determined that of the 67 men who had sex with men, anal HPV infection was found in 85%, LSIL in 49%, and HSIL in 12 patients 18%.

They identified risk factors for abnormal anal cytologic or histologic findings in injection drug users using univariate analysis. Risks included CD4+ cell counts less than 250 × 106 cells/l (odds ratio (OR) 5.7), plasma HIV RNA viral load greater than 1.7 log copies/ml (OR 8.9), previous AIDS-defining event (OR 4.3), and anal HPV detection (OR 5.7).

Risk factors among men who had sex with men included having more than 10 lifetime receptive anal intercourse episodes (OR 5.6) and anal HPV detection (OR 8.7).

Dr Christophe Piketty's team concluded, "Anal HPV infection and anal SIL may be acquired in the absence of anal intercourse in HIV-positive men".

"The prevalence of HSIL is high among HIV-positive injection drug users."

"All HIV-positive men with CD4+ cell counts less than 500 × 106 cells/L, regardless of history of anal intercourse, should be considered for anal cytologic screening.

"However, additional studies are needed to determine the efficacy of this procedure to prevent anal cancer in these populations."

Ann Intern Med 2003; 138: 453-9
24 March 2003

Go to top of page Email this page Email this page to a colleague

 22 November 2017 
Surgical treatment delays influence survival in colon cancer
 22 November 2017 
Golimumab in Crohn's disease
 22 November 2017 
Challenges of US-trained gastroenterologists when abroad
 21 November 2017 
Prepregnancy obesity and maternal mortality
 21 November 2017 
Preoperative optimization in IBD patients
 21 November 2017 
Cholangiopathy in critically ill patients
 20 November 2017 
Socioeconomic characteristics in diverticular disease
 20 November 2017 
Barriers to hepatitis C treatment
 20 November 2017 
Endoscopic indices of disease activity for Crohn’s
 17 November 2017 
Food elimination diets for treatment of adults with eosinophilic esophagitis
 17 November 2017 
PPI use and cognitive function in women
 17 November 2017 
Predicting microscopic colitis
 16 November 2017 
NAFLD-hepatocellular carcinoma and survival after orthotopic liver transplant
 16 November 2017 
Prepregnancy obesity and severe maternal morbidity
 16 November 2017 
Celiac disease screening in adult first-degree relatives
 15 November 2017 
Breastfeeding and the risk of IBD
 15 November 2017 
Predicting recurrence after curative rectal cancer surgery
 15 November 2017 
Medication nonadherence and health care costs
 14 November 2017 
Eosinophilic gastroenteritis and colitis
 14 November 2017 
HBV/HCV coinfection and cirrhosis
 14 November 2017 
Sexual dysfunction after rectal cancer surgery
 13 November 2017 
Flares after immunomodulator withdrawal in Crohn's
 13 November 2017 
Genetic polymorphisms, fatty acids and ulcerative colitis
 13 November 2017 
GI bleeding in patients taking non–vitamin K antagonist oral anticoagulants
 10 November 2017 
Thiopurines vs TNF and lymphoma risk in IBD
 10 November 2017 
Drug monitoring of anti-tumour necrosis factor therapy in IBD
 10 November 2017 
Treatment decisions for older patients with colorectal cancer
 09 November 2017 
Quality standards in upper gastrointestinal endoscopy
 09 November 2017 
Irradiated rectal cancer and chemoradiotherapy
 09 November 2017 
Environmental factors and IBD
 08 November 2017 
Prophylaxis of spontaneous bacterial peritonitis
 08 November 2017 
Optimal management of postoperative Crohn's disease
 07 November 2017 
Community Screening for Helicobacter pylori
 07 November 2017 
Early readmission in IBD patients
 07 November 2017 
Mesocolic excision for colon cancer
 06 November 2017 
Food elimination diet for children with eosinophilic esophagitis
 06 November 2017 
Biologic agents and obesity in children with IBD
 06 November 2017 
Liver cancer burden despite extensive use of antiviral agents
 03 November 2017 
Statins and mortality in chronic viral hepatitis
 03 November 2017 
Propofol for outpatient colonoscopy
 03 November 2017 
Asthma and IBD development
 02 November 2017 
Diverticulitis and emergency department burden
 02 November 2017 
Rural residence and risk of IBD
 02 November 2017 
Sexual functioning in Hep C
 01 November 2017 
Heartburn relief in adolescents with GERD
 01 November 2017 
Autoimmune pancreatitis in children
 31 October 2017 
Follow-up of positive results on fecal blood tests
 31 October 2017 
Surveillance in ulcerative colitis and Crohn’s disease
 30 October 2017 
Local recurrence after curative rectal cancer surgery
 30 October 2017 
Low-flow ascites pump in refractory cirrhosis
 30 October 2017 
Medical therapy of patients with pediatric-onset IBD
 27 October 2017 
NAFLD in advanced fibrosis in the USA
 27 October 2017 
Early readmission in cirrhosis after bacterial infections
 26 October 2017 
Predicting response to anti-TNF therapy in Crohn's
 26 October 2017 
Conversion to open laparotomy in rectal cancer
 25 October 2017 
Conversion of colonoscopy to sigmoidoscopy
 25 October 2017 
Rifaximin and survival in hepatic encephalopathy
 25 October 2017 
Fecal microbiota transplantation
 24 October 2017 
Eosinophilic esophagitis with swallowed topical corticosteroids
 24 October 2017 
Meta-analysis in nutritiona research

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us